Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed

Clinical trial NCT05533125 · COMPLETED

Trial details

NCT number: NCT05533125
Sponsor: Sint Maartenskliniek
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Polymyalgia Rheumatica

Start date: 2023-02-01
Primary completion: 2025-10-29
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.